# BIO KEY INTERNATIONAL INC (BKYI) — capital_raise/atm_program [announced]
Source: sec.gov · situation sit_6bad8e74af180db4e069 · public 1078095200451212287 · retrieved 2026-08-19T12:09:47.919Z

## Overview
BIO-key International, Inc. is a prepackaged software company providing biometric security and identity verification solutions.

On August 10, 2026, BIO-key International, Inc. entered into a warrant exercise agreement with an existing institutional investor (Armistice Capital Master Fund Ltd.) to exercise 618,334 outstanding warrants originally issued on October 28, 2025. The exercise price was reduced from $10.20 per share to $4.06 per share. In exchange, the investor received new unregistered warrants to purchase 1,236,668 shares of common stock at $4.06 per share, subject to a 4.99% beneficial ownership limitation. The new warrants are exercisable only upon stockholder approval and expire five years from such approval. The company received gross proceeds of approximately $2.51 million, with closing on August 11, 2026. The company agreed to file a resale registration statement within 90 days and to hold a stockholder meeting within 120 days to seek approval for the new warrants.

## Terms
- Counterparty: Armistice Capital Master Fund Ltd. · Deal value: $2.5M · Consideration: cash · Stake: 4.99% · Price/share: $4.06

## Key dates
- Announced 2026-08-13

## Timeline
- 2026-08-13 · 8-K (0001437749-26-027730): 8-K - BIO KEY INTERNATIONAL INC — *BIO-key International, Inc. is a prepackaged software company providing biometric security and identity verification solutions.* On August 10, 2026, BIO-key International, Inc. entered into a warrant exercise agreement with an existing institutional investor (Armistice Capital Master Fund Ltd.) to exercise 618,334 outstanding warrants originally issued on October 28, 2025. The exercise price was reduced from $10.20 per share to $4.06 per share. In exchange, the investor received new unregistered warrants to purchase 1,236,668 shares of common stock at $4.06 per share, subject to a 4.99% beneficial ownership limitation. The new warrants are exercisable only upon stockholder approval and expire five years from such approval. The company received gross proceeds of approximately $2.51 million, with closing on August 11, 2026. The company agreed to file a resale registration statement within 90 days and to hold a stockholder meeting within 120 days to seek approval for the new warrants.
  https://www.sec.gov/Archives/edgar/data/1019034/0001437749-26-027730.txt

## Citations
- 0001437749-26-027730 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000143774926027730